
Forever young: Sphk2 in HSCs, when less is more
- Daniel Herranz
- October 13, 2022
- kedalionlabs.com
- Victoria da Silva-Diz, Daniel Herranz, Victoria da Silva-Diz, Daniel Herranz
- Blood, 10.1182/blood.2022017932
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
- Daniel Herranz
- May 19, 2022
- kedalionlabs.com
- Natalia Baran, Alessia Lodi, Yogesh Dhungana, …, Stefano Tiziani, Trang Hoang, Marina Konopleva
- Nat Commun, 10.1038/s41467-022-30396-3
INTERFERing with the progression of T-cell acute lymphoblastic leukemia: a multifaceted therapy
- Daniel Herranz
- October 14, 2021
- kedalionlabs.com
- Daniel Herranz
- Haematologica, 10.3324/haematol.2021.279549
A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia
- Daniel Herranz
- April 20, 2021
- kedalionlabs.com
- Victoria da Silva-Diz, Bin Cao, Olga Lancho, …, Xiaoyang Su, Shengkan Jin, Daniel Herranz
- Blood, 10.1182/blood.2020008955
Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia
- Daniel Herranz
- January 7, 2021
- kedalionlabs.com
- Huizhong Xiong, Maicol Mancini, Michael Gobert, …, Daniel Herranz, Juan J Lafaille, Antonio Maraver
- Theranostics, 10.7150/thno.48067
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
- Juan C GarcÃa-Cañaveras, Olga Lancho, Gregory S Ducker, …, Hahn Kim, Daniel Herranz, Joshua D Rabinowitz
- Leukemia, 10.1038/s41375-020-0845-6
The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer
- Daniel Herranz
- November 25, 2018
- kedalionlabs.com
- Olga Lancho, Daniel Herranz
- Trends Cancer, 10.1016/j.trecan.2018.10.003